Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E7070 (Indisulam) in Advanced Renal Cell Carcinoma
NCT00059735Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- May 2002
- Modality
- RNA-Targeting Small Molecules, Molecular Glues
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial of indisulam in renal cell carcinoma (RCC), sponsored by Eisai Co., Ltd. Primary endpoint: Progression Free Survival. Started May 2002; status: completed.
02
Drugs
indisulam
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00059735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00059735.